Retina World Congress- Dr. Barbara Parolini

What makes Retina World Congress unique is that it is truly a global congress! Dr. Barbara Parolini (Italy) has spent the past 15 years studying Myopic Traction Maculopathy and discuses the best way in treating the disease. According to Dr. Parolini, MTM affects 1/3 of pathologic myopia (PM) eyes and is projected to affect roughly 1million people by 2050. Based on her research, Dr. Parolini has published the #MTM staging system and identified guidelines and treatment protocols per stage. Take a listen to this video and hear Dr. Parolini’s summary of her presentation at Retina World Congress 2024. References: Parolini. B. Macular Buckle for Myopic Traction Maculopathy: 15 Years Results on a Large Series of 270 Cases. Presented at: Retina World Congress; May 9-12, 2024; Fort Lauderdale, Florida. #retinadisease #mtm #macularbuckle #retinaworldcongress